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ABSTRACT
Vaccines are an important disease prevention strategy among individuals of all age
groups. Despite the success of vaccinations in preventing communicable diseases, adults, in
particular, often have sub-optimal vaccination rates. Consequently, some vaccine-preventable
diseases, such as pertussis, are still on the rise in the United States despite the availability of the
Tdap vaccine. As most adults can be found in the workplace, occupational health and
environmental health nurses (OHEHNs) are in a unique role to encourage employers to promote
adequate Tdap vaccination among their employees. As specific resources regarding Tdap
vaccination are lacking, the Pertussis Prevention Toolkit was developed to help OHEHNs
promote Tdap vaccination in the workplace.

Promoting Adult Pertussis Vaccinations in the Workplace
Pertussis is a highly contagious upper respiratory illness caused by the bacterium
Bordetella pertussis, a pathogen that can have serious and life-threatening consequences,
especially for children (Centers for Disease Control and Prevention [CDC], 2013a; Mooi, Van
Der Maas, & De Melker, 2014). The bacteria are transmitted when an infected person coughs or
sneezes, thus easily spreading the bacteria to others through respiratory droplets (United States
National Library of Medicine [USNLM], 2015). Symptoms of pertussis infection are similar to
symptoms associated with the common cold, including runny nose, fever, and diarrhea (USNLM,
2015). However, the most common symptom of pertussis is a distinctive cough, which can last
approximately 3 months. Pertussis is, in fact, often referred to as the 100 day cough (National
Foundation for Infectious Diseases, 2012). The cough is more severe in young children and
infants and is often accompanied by a “whoop” sound as the child or infant attempts to take a
breath following a violent coughing spell (USNLM, 2015). Though treatments for pertussis
infection are available, the CDC (2013b) highly recommends the tetanus, diphtheria, and
pertussis (Tdap) vaccination for adults and the diphtheria, tetanus, and pertussis vaccination for
infants and children as the single most important and preventive measure.
Vaccination rates are commonly promoted and tracked in children and, as a result,
vaccination uptake among the pediatric population is at an all-time high in the United States
(Children’s Hospital of Philadelphia [CHOP], 2013a). Such success is partly attributed to
childhood vaccination mandates in all 50 states, which must be met prior to school enrollment
(American Academy of Pediatrics, 2013). In contrast, very few adults are subjected to
vaccination mandates with the exception of a limited number of employees working with
children or in the healthcare environment (Immunization Action Coalition, 2014). Nevertheless,

vaccines are an important disease prevention strategy in children and adults alike. The Centers
for Disease Control and Prevention [CDC] (2014a) recommends all adults be vaccinated against
influenza yearly and vaccinated against pertussis if they did not receive booster vaccination as an
adolescent (CDC, 2014a). Furthermore, the Advisory Committee on Immunization Practices
now recommends routine pertussis vaccination for pregnant women during the third trimester
(Sawyer, Liang, Messonnier, & Clark, 2013). Additional adult vaccines may be needed,
depending on age, lifestyle, co-morbidities, employment, and international travel (CDC, 2014b).
More than 48,000 confirmed cases of pertussis were reported in the United States alone
during 2012, the highest incidence since 1955 (CDC, 2013c). Pertussis, however, is not a disease
limited to childhood. Individuals are believed to become susceptible to pertussis approximately
6-10 years after childhood vaccination (Sharland, 2011). While a classic “whooping” sound
often accompanies the cough in infants and children, in adults and adolescents the disease is
often unrecognized, undiagnosed, and underreported (Guiso, Liese, & Plotkin, 2011). As a
result, an estimated 600,000 to 900,000 unreported pertussis cases occur among adults and
adolescents each year in the United States (CHOP, 2013b). Despite the availability of a pertussis
booster vaccine, pertussis vaccination rates among adults remain sub-optimal at 14.2% (Williams
et al., 2014) and, as a result, contribute to the high incidence of pertussis in the United States
(Olyarchuk, Willoughby, Davis, & Newsom, 2012). Not surprisingly, hospitalizations and
deaths due to pertussis have also increased in the United States (Jakinovich & Sood, 2014).
The economic consequences of pertussis are notable, costing on average more than
$13,000 per hospitalization for adults and children (Clark, 2013). These estimated costs,
however, do not account for additional and indirect costs associated with the disease, including
time spent away from work or school, costs for follow-up provider appointments, recovering at

home, or prescriptions for medications continued once discharged from the hospital. Employees
infected with pertussis miss, on average, 6 days of work, although some may miss up to 77 days
(Lee et al., 2004). In the workplace, the spread of pertussis is especially problematic as
symptoms may develop anywhere from 5 days to 3 weeks after exposure (CDC, 2013a).
Unfortunately, during that time frame one undiagnosed person with pertussis can infect up to 15
other people, unaware he or she is sick or contagious (CDC, 2013d).
Occupational health and environmental health nurses (OHEHNs) are in an inimitable role
in the workplace, recognized as the “authority on health, safety, [and] productivity… for worker
populations” (American Association of Occupational Health Nurses [AAOHN], n.d.a, para. 3).
This role places occupational health and environmental health nurses in an ideal position to
educate adults in the workplace on the importance of Tdap vaccination. Though being up-todate on all vaccinations is an important disease prevention strategy, few resources are available
to help promote vaccination of adults against pertussis. Therefore, the purposes of this article are
to review a Utah program developed to promote pertussis vaccinations among adult employees
and share toolkit resources with OHEHNs as they strive to improve pertussis vaccination rates
among adult employees.
Evolution of Program and Development of the Pertussis Prevention Toolkit
In 2012, pertussis outbreaks in Utah were over three times higher than the national
incidence (CDC, 2013e). During 2013, 1,033 pertussis cases were reported in Utah and of those
diagnosed, 43% were over the age of 15 years (Utah Department of Health, 2013). While
healthcare providers are generally successful in assessing pertussis vaccination status of children
and ensuring they are up-to-date, pertussis vaccination is not always as closely monitored in the
adult population. In fact, healthcare providers often miss opportunities to vaccinate adults

against pertussis because they do not routinely assess the vaccination status of adult patients
(CDC, 2014c). As outbreaks of pertussis often stem from adults, it is important to identify
alternate locations wherein adult Tdap vaccination status can be assessed and appropriate
vaccinations, like Tdap, can be promoted beyond the outpatient clinic setting (CDC, 2015). In
Utah, 78% of adults work full-time (Lee, 2013), which is slightly higher than the national
employment average of 65.8% (Ryan & Newport, 2014). Therefore, place of employment is
where over half of all Utah adults, as well as American adults, can be reached with health-related
messages including vaccination information.
Knowing the majority of adults are found in the workplace setting provides an
opportunity to develop work specific resources to promote Tdap vaccination. The Pertussis
Prevention Toolkit was originally designed to provide education and resources to employers and
their employees regarding the importance of Tdap vaccination among adults in the workplace.
The initial toolkit materials were created by representatives from a local Utah health department,
university, pediatric offices and family practice offices, as well as pharmaceutical representatives
from several pharmaceutical manufacturers. Specific approaches were taken as the need for
different types of educational materials for employers and employees were recognized.
Materials were initially piloted among the 30 largest employers in Utah County, the second
largest county in Utah. After adaptation of the materials to fulfill the unique education needs and
requests among both the employees and the employers, the project was expanded. A more
inclusive directory of businesses was obtained from the Utah County Department of Workforce
Services. The document listed all licensed businesses in Utah County and included the ability to
sort businesses by name, city, and number of employees. During the second phase, the adult

Tdap vaccination program included the top 100 largest businesses in Utah County based upon
number of employees.
As employers were contacted via phone with a brief description of the project, some
requested additional information prior to scheduling meetings with a human resource or
health/wellness representative. An information packet with a one-page flyer providing facts
about pertussis in Utah and the importance of vaccination, along with a frequently asked
questions handout, was presented to the business representative. These printed materials
included information on pertussis transmission rates, the pertussis vaccination, potential costs
associated with pertussis outbreaks in the workplace, and available resources to assist the
employer in administering pertussis vaccinations to employees.
After meeting with the business representative, mobile vaccination clinics were
scheduled in collaboration with partners at the Utah County Health Department (UCHD)
Immunization Clinic and the Utah County Immunization Coalition. To make the vaccination
process convenient, the UCHD Immunization Clinic agreed to provide mobile vaccination clinics
at no additional cost to the employer. For employees with health insurance, the UCHD
Immunization Clinic directly billed the insurance company for the cost of the vaccine. In
addition, the UCHD Immunization Clinic offered pertussis vaccines at a discounted rate for
uninsured employees.
Some business representatives also requested development of a short presentation to
deliver in employee staff meetings prior to the mobile vaccination clinic date. Hence,
presentation materials were created with a focus on the importance of Tdap vaccination with a
general overview of other adult vaccines available during the mobile vaccination clinic. The
presentation included education on the incidence, symptoms, and treatment options for pertussis,

as well as graphs representing recent pertussis outbreaks in the local community. General
information regarding vaccine safety, potential contraindications, and common side effects of
Tdap was also included, as well as the importance of timely vaccination and what to bring to the
mobile vaccination clinic. After the presentation, a registered nurse from the health department
was available to answer additional questions or concerns.
Program Participation
Many businesses in Utah County participated in the program, allowing a scheduled date
for the mobile vaccination clinic and promotion of Tdap and other adult vaccines for their
employees. Of the 100 Utah County businesses contacted, 64 scheduled a day for the mobile
vaccination clinic during which a total of 4,080 vaccinations were administered between
February 2013 and September 2014.
While there has not yet been a significant decrease in pertussis cases in Utah County,
controlling the spread of pertussis in communities is a complex process confounded by multiple
factors such as achieving adequate vaccine immunogenicity, promoting regular booster uptake in
the population, and reaching pertussis vaccination rates of at least 92-94% to maintain a healthy
herd immunity (Guiso, 2013a; Plotkin, Orenstein, & Offit, 2013). Nevertheless, the most costeffective intervention at this time is to improve herd immunity by vaccinating adolescents and
adults (Guiso, 2013a; Guiso, 2013b).
Toolkit for Occupational Health and Environmental Health Nurses
Poor health outcomes of employees has the potential to cost American businesses about
$1 trillion every year, and OHEHNs are often charged with the task of maximizing employee
productivity and decreasing absenteeism in the workforce (AAOHN, 2012). Promoting uptake
of adult vaccinations is an important, effective strategy to promote health and prevent illness in

employee populations (AAOHN, 2012). Various vaccination toolkits exist, some of which are
specific to businesses, although most toolkits specifically address only influenza vaccine uptake.
Calculating a return on investment (ROI) and including such information in a vaccination
toolkit could be an effective strategy for demonstrating the economic benefit of employee
vaccinations (Singh, 2014). A quick Internet search of ROI calculators for influenza vaccination
are plentiful. While the ROI for influenza vaccination is dependent on various business qualities
such as number of employees and average employee income, generally speaking the ROI is 1:4,
meaning for every dollar spent on influenza vaccination, the employer can expect a $4 ROI
(Partnership for Prevention, 2012). In addition, the annual ROI of vaccinations in general have
been calculated between 12% and 18% worldwide (Andre et al., 2008). Unfortunately, however,
only one study thus far has attempted to calculate the ROI of Tdap in pertussis prevention, a
study that was conducted with healthcare employees of the Academic Medical Center in
Amsterdam (Tariq, Mangen, Hovels, Frijstein, & de Boer, 2015). Nevertheless, similar to
influenza vaccination the researchers reported an ROI of 1:4 when healthcare workers were
vaccinated against pertussis. That means that 4 Euros were saved for every 1 Euro spent in
pertussis vaccination (Tariq et al., 2015).

Information for the Employer

As on-site vaccination champions, OHEHNs can make employee vaccination suggestions

to business managers/owners, highlighting the health benefits of promoting Tdap vaccination as
well as the economic risk and potential impact of having an unvaccinated workforce. Generally
speaking, primary barriers to implementing a workplace vaccination program include concerns
regarding cost. However, vaccinating employees against pertussis has a cost benefit when
considering both direct employer costs of having an unvaccinated workforce- such as the average
number of work days missed for illness and decrease in productivity while ill at work- as well as

indirect costs associated with healthcare provider visits and antibiotic treatments (Coudeville,
Van Rie, Getsios, Caro, Crepey, & Nguyen, 2009). Other costs of pertussis include the average
number of missed work days for parents whose children also contract the illness (Joint
Commission on Accreditation of Healthcare Organizations, 2011).
Offering on-site vaccination clinics also has economic benefit for employees who are
traditionally vaccinated off-site, decreasing the amount of work time employees must miss to
travel to and from a traditional clinic setting to obtain their vaccinations (Mattke, Schnyer, &
Van Busum, 2012).
Currently, all health insurance marketplace plans and most private health insurance plans
cover the cost of Tdap (CDC, 2014d), thus removing any associated employer or employee outof-pocket expense. Even uninsured employees may be eligible for low cost Tdap vaccines
through a Federally-funded health center such as a local or state health department (CDC,
2014d).
The OHEHN may want to use these specific discussion points when suggesting on-site
vaccination clinics with the employer. Adaptable templates to create employer-specific handouts
or pamphlets are available at www.utahcountyimmunizationcoalition.org/toolkit (see Figures 1,
2, 3 and 4).

Information for the Employee

After obtaining employer approval for an on-site vaccination clinic, it is necessary to

educate employees regarding the importance of the Tdap vaccine in their professional as well as
personal life. While the employer’s chief vaccination concerns may be focused upon cost,
employees may have different concerns or educational deficits. Most commonly, adults are
inadequately vaccinated because they simply do not realize they need additional vaccines during
adulthood (CDC, 2014e). It is helpful, therefore, to provide information explaining the need for

adults to be vaccinated against pertussis. For instance, adult employees should understand their
childhood doses of pertussis wane with time, requiring a booster. Appropriate Tdap vaccination
helps employees prevent absenteeism and decreases healthcare costs associated with
medications, provider visits, and in some cases, hospitalization.
Employee education should include basic information not only about vaccine side effects,
but the pertussis infection, including local pertussis statistics, how long the employee can expect
to be ill, symptoms of the pertussis disease, disease incubation period, and how many days of
work the employee could expect to miss (see Figure 3). The OHEHN may want to consider
using an educational PowerPoint when discussing these points, an example of which can be
downloaded and easily adapted at www.utahcountyimmunizationcoalition.org/toolkit.
Furthermore, OHEHNs may also want to highlight the importance of being vaccinated with
Tdap, not only for the employee’s health benefit, but to also protect the health of his or her loved
ones, including vulnerable family members such as aging parents, infants and children (CDC,
2013b).
When promoting Tdap vaccination among employees, OHEHNs may also want to
include information on various items employees should bring to the mobile vaccination clinic.
Such items may include the employee’s health insurance card, photo identification, list of
employee allergies, personal vaccination record, co-pay if applicable, and acceptable forms of
payment. If the mobile vaccination clinic also vaccinates dependents of the employee, similar
items should be presented for each dependent.

Suggestions for Occupational Health and Environmental Health Nurses

Mobile vaccination clinics can be scheduled after identifying a source of vaccinations.

OHEHNs may consider collaborating with local health departments and inquiring about the
possibility of a mobile vaccination clinic. If mobile vaccination clinics are not offered through

the local or state health department, consider contracting with a mobile vaccination nursing
service, local healthcare provider office, or local hospital facility. The insurance company
primarily responsible for providing healthcare benefits to employees may also be able to assist in
identifying a local nursing service that offers mobile vaccination clinic services to businesses. If,
after exhausting the aforementioned options, scheduling an on-site vaccination clinic is not
possible, consider distributing vouchers to employees that can be exchanged for vaccination at a
local healthcare facility.
As the date for the mobile vaccination clinic approaches, the clinic should be promoted
within the workplace. To boost attendance, OHEHNs may want to consider sending reminder
emails 5-7 days prior to the clinic and/or posting information with the date and time of the clinic
in high population areas, such as break rooms or near a time clock. A sample vaccination clinic
poster is available, at no cost, for download to promote the vaccination clinic at
http://www.utahcountyimmunizationcoalition.org/Figure%205%20Immunization%20Clinic.pdf
(See Figure 5).
Though the Tdap vaccination is not seasonal in nature and may be administered at any
time of year, OHEHNs may want to consider simultaneously promoting Tdap with seasonal
influenza vaccines. If annual influenza vaccination clinics are already a routine event at the
workplace, consider querying the mobile vaccination service about offering Tdap vaccinations in
addition to influenza vaccines. Tdap and influenza vaccinations may be administered
concurrently (Immunization Action Coalition, 2011).
While pertussis outbreaks are common in the United States, it may be helpful to offer
local pertussis-related statistics in addition to national data as statistics vary from state to state.
Being familiar with the number of pertussis cases per state or county may help the employee

understand their risk for contracting the illness. The number of pertussis cases per state is
available and updated each week by the CDC, and can be accessed at http://www.cdc.gov/
mmwr/preview/mmwrhtml/mm6252md.htm?s_cid=mm6252md_w. In addition, state health
departments routinely report the number of pertussis cases, categorized by county, on individual
state websites.
Supplementary web-based resources are also available to OHEHNs who wish to promote
vaccinations among workers. Such resources, found at
www.utahcountyimmunizationcoalition.org/toolkit, can be utilized to augment the Pertussis
Prevention Toolkit. For example, a Tdap Vaccine Information Statement (VIS) can be
downloaded from the CDC website: http://www.cdc.gov/vaccines/hcp/vis/visstatements/tdap.html. These supplementary resources are listed in Table 1.
Implications for Occupational Health and Environmental Health Nurses
Offering adult vaccinations to employees in the workplace is an important strategy for
increasing adult vaccination rates and, as a result, lowering an employee’s risk of developing a
vaccine-preventable disease. Two strong determinants of whether or not an employee receives
vaccinations include: 1) if the vaccination is offered in the workplace; and 2) if the vaccinations
are free to employees (Ofstead et al., 2013). Indeed, adults without high-risk health conditions
are more likely to be adequately vaccinated when vaccinations are offered in a nontraditional and
nonmedical setting (Lu et al., 2014), such as the workplace. Thus, while the traditional clinic
setting is often utilized to administer adult vaccines, the workplace is a suitable and effective
nonmedical site for adult vaccination (Lu et al., 2014).
Because OHEHNs are in a unique position to promote health and reduce communicable
disease risk among employees in the workplace, OHEHNs can positively influence Tdap

vaccination rates among workers. When promoted by OHEHNs, a work-based vaccination
program is an effective strategy to reduce the number of vaccine-preventable diseases in the
workplace, and is an integral part of keeping workers healthy and productive (AAOHN, n.d.b).
Conclusion
Appropriate vaccination among all age groups and populations is an important strategy to
reduce the spread of vaccine-preventable communicable diseases. Despite availability of a
pertussis vaccine, Tdap vaccination rates among American adults remain sub-optimal. As a
result, the incidence of pertussis in the United States is unacceptably high. Adequate vaccination
of highly virulent and contagious diseases, such as pertussis, provides many economic benefits.
While several toolkits are available to promote influenza vaccination among adults, such
resources specifically addressing pertussis vaccination were lacking in the literature. The
purposes of this article were to review a Utah program developed to promote pertussis
vaccinations among adult employees as well as to share pertussis-specific toolkit resources with
OHEHNs. All healthcare providers share the responsibility of ensuring adequate vaccination of
adults. However, since over half the adult population in America is employed, OHEHNs are in a
unique, influential position to promote adult vaccinations in the workplace. The Pertussis
Prevention Toolkit is a valuable resource now available to help OHEHNs develop, promote, and
implement a successful adult immunization program.
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Table 1: Additional Web-based Resources
Description/Title

Web Address

Tdap Vaccine Information
Statement

http://www.cdc.gov/vaccines/hcp/vis/visstatements/tdap.html

All Vaccine Information
Statements

http://www.cdc.gov/vaccines/hcp/vis/index.html

2014 Recommended
Immunizations for Adults by Age

http://www.cdc.gov/vaccines/schedules/downloads/adult
/adult-schedule-easy-read.pdf

Top Reasons to Get Vaccinated

http://www.nfid.org/about-vaccines/reasons

Young Adults Need Vaccines, Too

http://www.cdc.gov/features/adultimmunizations/

Free Subscriptions to Periodicals
and Email News Service

http://www.immunize.org/subscribe/?gclid=Cj0KEQjwq
uOhBRCupYiu4an13scBEiQAss2XklMG7QzV5VFQAc
ETs2kyy_1VvsHHpjZHEx_2kDMz2DYaAtib8P8HAQ

Recommendations from the
National Vaccine Advisory
Committee: Standards for Adult
Immunization Practice

http://www.hhs.gov/nvpo/nvac/reports/nvacstandards.pdf

Adult Vaccination Information for
Healthcare and Public Health
Professionals

http://www.cdc.gov/vaccines/hcp/patiented/adults/index.html

What Vaccines do You Need?

http://www2a.cdc.gov/nip/adultImmSched/

Immunization Courses:
Broadcasts, Webcasts, and Self
Study

http://www.cdc.gov/vaccines/ed/courses.htm

PERTUSSIS
(Whooping Cough)
What is Pertussis?

•

•

•

•

Pertussis is a highly contagious respiratory disease
o A person with pertussis can infect up to 15 other people
o The incubation period for pertussis can be up to 3 weeks
 The incubation period is the time from when someone is
exposed
to a disease to when they start to develop symptoms
All adults are at risk
o There were [insert number of outbreaks] in [insert state] in [insert
year]
o There were [insert number of outbreaks] in the United States in
[insert year]
o Many adults pertussis cases go unreported and untreated
One of the most common symptoms adults with pertussis may develop is a
cough that can last up to 3 months
o Other complications may include vomiting, pneumonia, rib fractures,
and even seizures
Infants and children are often exposed to pertussis by an adult
o Parents lose an average of 6 workdays (but can loose up to as many
as 77 days) to care for ill family members
o The cost for a hospitalization related to pertussis is approximately
$13,000

What can you do about it?
•

The best way to avoid getting pertussis is to get the Tdap vaccine
o The Tdap vaccine is recommended at least once every ten years
o Most insurance companies cover the cost of immunizations which
means little to no out-of-pocket expense

Get your Tdap vaccine today!
Information obtained from www.cdc.gov/pertussis
Flyer can be downloaded for distribution at www.utahcountyimmunizationcoalition.org

To find the number of outbreaks in your area, go to
www.cdc.gov/mmwr/publications/index.html, Weekly Report, Notifiable Diseases and
Mortality Tables, then Pertussis.

Figure 2: Employer Handout FAQ

Figure 3: Employer and Employee Handout “What’s the Big Deal About Pertussis?”

Did you know that [insert vaccine
service] could hold a

Protect
Yourself
and Your
Employees.

Vaccination Clinic
at your business, for your staff?
Each year in the U.S., up to 30,000
adults die from vaccine preventable
diseases or their complications.
70% of adults do not have all the
recommended vaccines.

Do what you can to protect
your staff!

[Insert contact information]

[Insert desired logo or picture]

[Insert return address]

For more information contact:

Get
Immunized!
[Insert company name]
Immunization Clinic

Pertussis
(Whooping Cough)
DID YOU KNOW…
•

In 2012, 48,277 CASES of pertussis were
reported in the United States.

•

The last time the rates of Whooping Cough were
this high was in 1955, 10 years after the vaccine
was created.

•

There were [insert number of cases] CASES of
Whooping Cough in [insert your state] in [insert
year].

•

Whooping cough causes a prolonged cough for
adults and can be FATAL for infants and young
children.

WHY DOES THIS MATTER TO YOU AND YOUR
COMPANY?
•

The average person who gets Pertussis will
cough for 100 DAYS. This causes an average of
6 DAYS of calling in sick to work.

•

Insured employees pay
• [Insert insurance company]:
[Insert out-of-pocket cost]
• [Insert additional insurance
companies and respective
out-of-pocket costs, if
applicable]

Pertussis is highly contagious. An employee with
pertussis could be contagious for 1 to 6 WEEKS
before showing any symptoms. If one of your
employees gets pertussis, he or she could spread
it to 15 PEOPLE.

•

Out-of-Pocket Expense

Uninsured employees pay [insert
out-of-pocket cost]

VACCINATE your employees so you won’t end
up with an outbreak.
vaccination clinic.

•

[Insert vaccine service] will bring a MOBILE
CLINIC that will come to your company to
vaccinate your employees.

TAKE THIS OPPORTUNITY to protect YOURSELF, your
FAMILY, your EMPLOYEES, and your COMPANY from the
AWFUL EFFECTS of pertussis.

Measles, Mumps, Rubella—MMR (2 doses
for all adults born after 1957)
Varicella (2 doses for adults under 60 who
have never had chickenpox)

Pneumococcal (1 dose for adults 65 or older
or adults with high-risk conditions**)

WHAT CAN YOU DO ABOUT IT?

CALL [INSERT VACCINE SERVICE] to set up a

Human papillomavirus—HPV (3 doses for
females 11-26 years of age)

Influenza (annual vaccination for all adults**)

OUTBREAK at your company.

•

Tetanus, Diphtheria, Pertussis—Tdap*/Td
(every 10 years for all adults)

Zoster (1 dose for adults 60 and over)

If only 1 EMPLOYEE comes to work after being
exposed to pertussis, you will likely have an

•

Recommended Adult
Vaccines

To find the number of outbreaks for your area, go
to www.cdc.gov/mmwr/publications/index.html,
Weekly Report, Notifiable Diseases and Mortality
Tables, then Pertussis.

Hepatitis A (2 doses for adults at risk** or
wishing immunity)
Hepatitis B (3 doses for adults at risk**)
Meningococcal (1 or more doses for adults at
risk**)
*Substitute 1 dose of Tdap for Td
**Influenza vaccination is especially important for adults with
certain high-risk conditions. Ask your health care provider if
you have a condition that puts you at higher risk.

Figure 5: Promotional Vaccination Clinic Poster

